"For the first time, we found that empagliflozin, an established diabetes and heart medication, reduced markers of brain ...

Two existing medications show promise in improving brain health and cognitive function in early Alzheimer’s disease.

Village Caregiving reports that frontotemporal dementia is a progressive brain disease affecting behavior, speech, and memory ...

One million people in the UK currently live with dementia and this number is expected to rise to 1.4 million by 2040.